ÂÜÀòÂÒÂ×

Viviana Volta, PhD, currently serves as the Scientific Lead at Eli Lilly and Company, where responsibilities include coordinating preclinical studies to support Lilly Precision Oncology clinical trials. In addition, Viviana holds an advisory role at DNA ID and previously worked as a Senior Scientist at Opentrons' Pandemic Response Lab, overseeing teams in the development of automated qPCR and ELISA assays. As a Senior Scientist at Synthis, Viviana established cell-based assays and managed laboratory operations that contributed to securing seed-stage investments. Earlier career highlights include a postdoctoral fellowship at NYU Langone Health, where Viviana led NIH-funded projects on drug-induced regulatory T cell differentiation and received multiple accolades for research presentations. Viviana's academic background includes PhDs in Biology and Biochemistry from Ospedale San Raffaele, with early research showcasing significant findings in mesothelioma treatment efficacy and ribosomal protein synthesis regulation.